Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance. Journal of Cancer Research Updates, [S. l.], v. 2, n. 4, p.  306–317, 2013. DOI: 10.6000/1929-2279.2013.02.04.9. Disponível em: https://www.neoplasiaresearch.com/index.php/jcru/article/view/428. Acesso em: 21 may. 2026.